Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$8.79 - $11.51 $1.86 Million - $2.43 Million
-211,324 Reduced 37.85%
347,016 $3.97 Million
Q3 2023

Nov 14, 2023

SELL
$8.25 - $11.35 $93,068 - $128,039
-11,281 Reduced 1.98%
558,340 $5.38 Million
Q2 2023

May 17, 2024

BUY
$10.1 - $11.6 $5.75 Million - $6.61 Million
569,621 New
569,621 $6.06 Million
Q2 2023

Aug 14, 2023

BUY
$10.1 - $11.6 $160,034 - $183,802
15,845 Added 2.86%
569,621 $6.06 Million
Q1 2023

May 17, 2024

BUY
$10.37 - $12.56 $3.74 Million - $4.53 Million
360,341 Added 186.29%
553,776 $5.83 Million
Q1 2023

May 15, 2023

BUY
$10.37 - $12.56 $3.74 Million - $4.53 Million
360,341 Added 186.29%
553,776 $5.83 Million
Q4 2022

May 17, 2024

BUY
$9.9 - $12.43 $1.92 Million - $2.4 Million
193,435 New
193,435 $2.4 Million
Q4 2022

Feb 14, 2023

SELL
$9.9 - $12.43 $353,915 - $444,360
-35,749 Reduced 15.6%
193,435 $2.4 Million
Q3 2022

Nov 14, 2022

BUY
$10.14 - $12.38 $39,322 - $48,009
3,878 Added 1.72%
229,184 $2.37 Million
Q2 2022

Aug 15, 2022

BUY
$11.05 - $12.72 $1.58 Million - $1.82 Million
142,939 Added 173.54%
225,306 $2.6 Million
Q1 2022

May 16, 2022

BUY
$10.61 - $12.88 $873,913 - $1.06 Million
82,367 New
82,367 $1.04 Million
Q2 2018

Aug 14, 2018

SELL
$11.83 - $16.2 $3.89 Million - $5.33 Million
-328,993 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$11.13 - $13.63 $3.66 Million - $4.48 Million
328,993 New
328,993 $5.08 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $607M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Portfolio

Follow Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.